C-reactive protein levels and risk of disabling dementia with and without stroke in Japanese: The Circulatory Risk in Communities Study (CIRCS)

Atherosclerosis

Volumn 236, Issue 2, 2014, Pages 438-443

  Chei, Choy Lye ^a,b   Yamagishi, Kazumasa ^b,c,i   Ikeda, Ai ^d,k   Noda, Hiroyuki ^e,j   Maruyama, Minako ^e,j   Cui, Renzhe ^e,j   Imano, Hironori ^e,j   Kiyama, Masahiko ^c   Kitamura, Akihiko ^c,e,j   Asada, Takashi ^b   Iso, Hiroyasu ^e,j   Nakamura, Masakazu ^c,h   Okada, Takeo ^c   Maeda, Kenji ^c   Ido, Masatoshi ^c   Yao, Masayuki ^c   Kajiura, Mitsugu ^c   Ishikawa, Yoshinori ^c   Konishi, Masamitsu ^c   Shimamoto, Takashi ^c   Ozawa, Hideki ^c   Iida, Minoru ^c   Komach, Yoshio ^c   Naito, Yoshihiko ^f   Sato, Shinichi ^g   Sankai, Tomoko ⁱ   Umesawa, Mitsumasa ⁱ   Chei, ChoyLye ⁱ   Tabata, Minako ⁱ   Ikehara, Satoyo ^j   Shimizu, Yuji ^j   Muraki, Isao ^j   Nagao, Masanori ^j   Tanigawa, Takeshi ^k   Ohira, Tetsuya ^l   Saito, Isao ^m   Sakurai, Susumu ^m   Hitsumoto, Shinichi ^m   Maruyama, Kotatsu ^m   Eguchi, Eri ^m   more..

^a DUKE NUS MEDICAL SCHOOL   (Singapore)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c Osaka Center for Cancer and Cardiovascular Diseases Prevention   (Japan)

^d JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

^g CHIBA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^h NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

ⁱ UNIVERSITY OF TSUKUBA   (Japan)

^j OSAKA UNIVERSITY   (Japan)

^k JUNTENDO UNIVERSITY   (Japan)

^l FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^m EHIME UNIVERSITY   (Japan)

more..

Author keywords

Dementia; Hs CRP; Japanese; Stroke

Indexed keywords

C REACTIVE PROTEIN; LATEX; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONFOUNDING VARIABLE; DEMENTIA; DIABETES MELLITUS; DISABLING DEMENTIA; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; COMORBIDITY; DRINKING BEHAVIOR; EPIDEMIOLOGY; HEALTH SURVEY; HYPERCHOLESTEROLEMIA; JAPAN; MIDDLE AGED; MULTICENTER STUDY; PSYCHOLOGY; SMOKING; STROKE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; BIOMARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; COMORBIDITY; CONFOUNDING FACTORS (EPIDEMIOLOGY); DEMENTIA; DIABETES MELLITUS; FEMALE; HEALTH SURVEYS; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; JAPAN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SMOKING; STROKE;

EID: 84907070485     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.07.036     Document Type: Article

References (45)

1. National Institute of Population and Social Security Research in Japan Population projections for Japan (January 2012) 2011 to 2060, Available at:, [accessed June, 2013]. http://www.ipss.go.jp/site-ad/index_english/esuikei/ppfj2012.pdf.
2. Health and Welfare Statistics Association Trends for national hygiene 2007 [in Japanese]. J Health Welf Stat 2007, 34:47-54. 168-170.
3. Murray C.J., Vos T., Lozano R., Naghavi M., Flaxman A.D., Michaud C., et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the global burden of disease study 2010. Lancet 2012, 380:2197-2223.
4. Feigin V.L., Lawes C.M., Bennett D.A., Anderson C.S. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2003, 2:43-53.
5. Tatemichi T.K., Paik M., Bagiella E., Desmond D.W., Stern Y., Sano M., et al. Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study. Neurology 1994, 44:1885-1891.
6. Anstey K.J., Lipnicki D.M., Low L.F. Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis. Am J Geriatr Psychiatry 2008, 16:343-354.
7. C1 Reitz, Tang M.X., Luchsinger J., Mayeux R. Relation of plasma lipids to Alzheimer disease and vascular dementia. Arch Neurol 2004, 61:705-714.
8. Moroney J.T., Tang M.X., Berglund L., Small S., Merchant C., Bell K., et al. Low-density lipoprotein cholesterol and the risk of dementia with stroke. J Am Med Assoc 1999, 282:254-260.
9. Zacho J., Tybjaerg-Hansen A., Jensen J.S., Grande P., Sillesen H., Nordestgaard B.G. Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med 2008, 359:1897-1908.
10. Ridker P.M. High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit. Am Heart J 2004, 148(1 Suppl.):S19-S26.
11. Chei C.L., Yamagishi K., Kitamura A., Kiyama M., Imano H., Ohira T., et al. C-reactive protein levels and risk of stroke and its subtype in Japanese: the Circulatory Risk in Communities Study (CIRCS). Atherosclerosis 2011, 217:187-193.
12. Iso H., Noda H., Ikeda A., Yamagishi K., Inoue M., Iwasaki M., et al. The impact of C-reactive protein on risk of stroke, stroke subtypes, and ischemic heart disease in middle-aged Japanese: the Japan public health center-based study. J Atheroscler Thromb 2012, 19:756-766.
13. Schmidt R., Schmidt H., Curb J.D., Masaki K., White L.R., Launer L.J. Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol 2002, 52:168-174.
14. Engelhart M.J., Geerlings M.I., Meijer J., Kiliaan A., Ruitenberg A., van Swieten J.C., et al. Inflammatory proteins in plasma and the risk of dementia: the Rotterdam study. Arch Neurol 2004, 61:668-672.
15. Ravaglia G., Forti P., Maioli F., Chiappelli M., Montesi F., Tumini E., et al. Blood inflammatory markers and risk of dementia: the Conselice Study Of Brain Aging. Neurobiol Aging 2007, 28:1810-1820.
16. Koyama A., O'Brien J., Weuve J., Blacker D., Metti A.L., Yaffe K. The role of peripheral inflammatory markers in dementia and Alzheimer's disease: a meta-analysis. J Gerontol A Biol Sci Med Sci 2013, 68:433-440.
17. Weuve J., Ridker P.M., Cook N.R., Buring J.E., Grodstein F. High-sensitivity C-reactive protein and cognitive function in older women. Epidemiology 2006, 17:183-189.
18. Kravitz B.A., Corrada M.M., Kawas C.H. High levels of serum C-reactive protein are associated with greater risk of all-cause mortality, but not dementia, in the oldest-old: results from the 90+Study. J Am Geriatr Soc 2009, 57:641-646.
19. Tan Z.S., Beiser A.S., Vasan R.S., Roubenoff R., Dinarello C.A., Harris T.B., et al. Inflammatory markers and the risk of Alzheimer disease: the Framingham study. Neurology 2007, 68:1902-1908.
20. Dik M.G., Jonker C., Hack C.E., Smit J.H., Comijs H.C., Eikelenboom P. Serum inflammatory proteins and cognitive decline in older persons. Neurology 2005, 64:1371-1377.
21. van Himbergen T.M., Beiser A.S., Ai M., Seshadri S., Otokozawa S., Au R., et al. Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and Alzheimer disease: results from the Framingham Heart Study. Arch Neurol 2012, 69:594-600.
22. Imano H., Kitamura A., Sato S., Kiyama M., Ohira T., Yamagishi K., et al. Trends for blood pressure and its contribution to stroke incidence in the middle-aged Japanese population: the circulatory risk in communities study (CIRCS). Stroke 2009, 40:1571-1577.
23. Rumley A., Emberson J.R., Wannamethee S.G., Lennon L., Whincup P.H., Lowe G.D. Effects of older age on fibrin D-dimer, C-reactive protein, and other hemostatic and inflammatory variables in men aged 60-79 years. J Thromb Haemost 2006, 4:982-987.
24. Hutchinson W.L., Koenig W., Frohlich M., Sund M., Lowe G.D., Pepys M.B. Immunoradiometric assay of circulating C-reactive protein: age-related values in the adult general population. Clin Chem 2000, 46:934-938.
25. Zwaka T.P., Hombach V., Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation 2001, 103:1194-1197.
26. Campbell J.C., Ikegami N. Long-term care insurance comes to Japan. Health Aff (Millwood) 2000, 19:26-39.
27. Matsuda S., Yamamoto M. Long-term care insurance and integrated care for the aged in Japan. Int J Integr Care 2001, 1:e28.
28. Health and Welfare Bureau for the Elderly of Japan Standardized assessment manual for the levels of activity daily living deficiencies among elderly with dementia 1993, [in Japanese], Tokyo, Ministry of Health, Labour and Welfare.
29. Levy R. Aging-associated cognitive decline. Working party of the international psychogeriatric association in collaboration with the World Health Organization. Int Psychogeriatr 1994, 6:63-68.
30. Ikeda A., Yamagishi K., Tanigawa T., Cui R., Yao M., Noda H., et al. Cigarette smoking and risk of disabling dementia in a Japanese rural community: a nested case-control study. Cerebrovasc Dis 2008, 25:324-331.
31. Iso H., Rexrode K., Hennekens C.H., Manson J.E. Application of computer tomography-oriented criteria for stroke subtype classification in a prospective study. Ann Epidemiol 2000, 10:81-87.
32. Shimamoto T., Komachi Y., Inada H., Doi M., Iso H., Sato S., et al. Trends for coronary heart disease and stroke and their risk factors in Japan. Circulation 1989, 79:503-515.
33. Rothman K., Greenland S. Modern epidemiology 1998, 93-99. Lippincott Williams & Wilkins, Philadelphia. 2nd ed.
34. Rifai N., Tracy R.P., Ridker P.M. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 1999, 45:2136-2141.
35. Verma S., Wang C.H., Li S.H., Dumont A.S., Fedak P.W., Badiwala M.V., et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 2002, 106:913-919.
36. Dolan H., Crain B., Troncoso J., Resnick S.M., Zonderman A.B., Obrien R.J. Atherosclerosis, dementia, and Alzheimer disease in the baltimore longitudinal study of aging cohort. Ann Neurol 2010, 68:231-240.
37. Chantal S., Braun C.M., Bouchard R.W., et al. Similar 1H magnetic resonance spectroscopic metabolic pattern in the medial temporal lobes of patients with mild cognitive impairment and Alzheimer disease. Brain Res 2004, 1003:26-35.
38. Eagan D.E., Gonzales M.M., Tarumi T., Tanaka H., Stautberg S., Haley A.P. Elevated serum C-reactive protein relates to increased cerebral myoinositol levels in middle-aged adults. Cardiovasc Psychiatr Neurol 2012, 2012:120540.
39. Sundelo¨f J., Kilander L., Helmersson J., Larsson A., Ro¨nnemaa E., Degerman-Gunnarsson M., et al. Systemic inflammation and the risk of Alzheimer's disease and dementia: a prospective population-based study. J Alzheimers Dis 2009, 18:79-87.
40. Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer disease meta analysis consortium. J Am Med Assoc 1997, 278:1349-1356.
41. Hubacek J.A., Peasey A., Pikhart H., Stavek P., Kubinova R., Marmot M., et al. APOE polymorphism and its effect on plasma C-reactive protein levels in a large general population sample. Hum Immunol 2010, 71:304-308.
42. Judson R., Brain C., Dain B., Windemuth A., Ruano G., Reed C. New and confirmatory evidence of an association between APOE genotype and baseline C-reactive protein in dyslipidemic individuals. Atherosclerosis 2004, 177:345-351.
43. Haan M.N., Aiello A.E., West N.A., Jagust W.J. C-reactive protein and rate of dementia in carriers and non carriers of apolipoprotein APOE4 genotype. Neurobiol Aging 2008, 29:1774-1782.
44. Nilsson T.K., Boman K., Jansson J.H., Thogersen A.M., Berggren M., Broberg A., et al. Comparison of soluble thrombomodulin, von Willebrand factor, tPA/PAI-1 complex, and high-sensitivity CRP concentrations in serum, EDTA plasma, citrated plasma, and acidified citrated plasma (stabilyte) stored at -70 degrees C for 8-11 years. Thromb Res 2005, 116:249-254.
45. Pepys M.B., Hirschfield G.M. C-reactive protein: a critical update. J Clin Invest 2003, 111:1805-1812.